Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes

Eye (Basingstoke)

Volumn 27, Issue 5, 2013, Pages 612-620

  Karakus, S H ^a   Basarir, B ^a   Pinarci, E Y ^b   Kirandi, E U ^a   Demirok, A ^a  

^a Beyoglu Eye Training and Research Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

central serous chorioretinopathy; contrast sensitivity; functional acuity contrast test (FACT); photodynamic therapy; verteporfin

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTRAST SENSITIVITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; FUNCTIONAL ACUITY CONTRAST TEST; FUNCTIONAL VISION TESTING EQUIPMENT; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; RETINAL THICKNESS; RISK ASSESSMENT; SUBRETINAL FLUID; VISION TEST; VISUAL ACUITY;

EID: 84877672388     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.24     Document Type: Article

References (31)

1. Gass JD. Pathogenesis of disciform detachment of neuroepithelium. Am J Ophthalmol 1967; 63: 587-615.
2. Yannuzzi LA. Type-A behaviour and central serous chorioretinopathy. Retina 1987; 7: 111-131.
3. Yannuzzi LA, Gitter KA, Schatz H. Central serous chorioretinopathy. In: The macula: A Comprehensive Text and Atlas. Williams and Wilkins: Baltimore, USA; 1979. pp 145-165.
4. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984; 91: 1554-1572.
5. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR et al. Central serous chorioretinopathy in older and younger adults. Ophthalmology 1996; 103: 2070-2079.
6. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hope-Ross M, Orlock DR. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112: 1057-1062.
7. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121: 26-34.
8. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 1993; 115: 50-56.
9. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994; 14: 231-242.
10. Spaide RF, Hall H, Haas A, Campeas L, Yannuzzi LA, Fisher YL et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996; 16: 203-213.
11. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ et al. Indocyanine green angiography-guided photodynamic therapy for treatment ofchronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288-298.
12. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23: 752-763.
13. Shanmugam PM, Agarwal M. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2004; 24: 988-989.
14. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004; 137: 1073-1080.
15. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453-1458.
16. Colucciello M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 2006; 26: 239-242.
17. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006; 90: 869-874.
18. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008; 28(1): 85-93.
19. Lim JW, Kang SW, Kim YT, Chung SE, Lee SW. Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy. Br J Ophthalmol 2011; 95(4): 514-517.
20. Jirarattanasopa P, Ratanasukon M, Bhurayanontachai P. The one-year results of half-dose photodynamic therapy with verteporfin in chronic or recurrent central serous chorioretinopathy. J Med Assoc Thai 2012; 95(Suppl 4): S56-S60.
21. Nicolò M, Zoli D, Musolino M, Traverso CE. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy. Am J Ophthalmol 2012; 153(3): 474-480.
22. Ginsburg AP. Clinical findings from a new contrast sensitivity test chart. In: Fiorentini A, Guyton DL, Siegel IM (eds). Advances in Diagnostic Visual Optics. Springer-Verlag: Berlin, Germany, 1987, pp 132-145.
23. Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Retina 2011; 31(9): 1912-1920.
24. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010; 149(3): 441-446.
25. Uetani R, Ito Y, Oiwa K, Ishikawa K, Terasaki H. Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy. Eye 2012; 26(5): 640-649.
26. Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005; 139(1): 87-99.
27. Mudvari SS, Goff MJ, Fu AD, McDonald HR, Johnson RN, Ai E et al. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina 2007; 27(9): 1168-1173.
28. Wu ZH, Lai RY, Yip YW, Chan WM, Lam DS, Lai TY. Improvement in multifocal electroretinography after halfdose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial. Retina 2011; 31(7): 1378-1386.
29. Fujita K, Yuzawa M, Mori R. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 2011; 31(4): 772-778.
30. Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O. Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 2011; 151(2): 303-309.
31. Fujita K, Shinoda K, Imamura Y, Matsumoto CS, Mizutani Y, Mizota A et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol 2012; 154(3): 579-585.